A case study compares capital costs, operating expenses, and net present value for a new MAb plant.
Dec 1, 2009
By:
José M. País-Chanfrau, Katia Zorrilla, Ernesto Chico
A case study compares capital costs, operating expenses, and NPV for a new MAb plant.
|
By incorporating disposable technologies and an improved purification scheme, scale-up and validation problems were resolved.
Oct 2, 2008
By:
Gryssell Rodriguez, Airama Albisa, Lisel Viña, Ariadna Cuevas, Beatriz Garcia, Aurora Tamara Garcia, Alejandro Portillo, Loany Calvo, Tania Crombet, Gisela Gonzalez, Ernesto Chico
The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.
|
|
